Suppr超能文献

人血浆纤连蛋白的潜在蛋白水解活性。

Potential proteolytic activity of human plasma fibronectin.

作者信息

Keil-Dlouha V, Planchenault T

出版信息

Proc Natl Acad Sci U S A. 1986 Aug;83(15):5377-81. doi: 10.1073/pnas.83.15.5377.

Abstract

Evidence is presented that fibronectin (FN) polypeptide chain contains a latent proteinase. Human plasma FN was cleaved with cathepsin D into three main fragments: 140-kDa and 70-kDa single-chain and 140-kDa double-chain polypeptides. Their separation was achieved according to their affinity for heparin-Sepharose. A single-chain 140-kDa fragment (H-1) was eluted in the first peak. This peptide corresponds to the already described fragment that originates from the central part of FN; it contains a low-affinity heparin-binding site, one free SH group, and a cell-binding site. After reduction and further purification by preparative polyacrylamide gel electrophoresis, this fragment revealed a spontaneous decomposition, which could be attributed to proteolytic degradation. The subfragments, ranging from 25 to 95 kDa, yielded the same proteolytically active doublet of 28-30 kDa when tested by NaDodSO4/polyacrylamide gel electrophoresis in a gel containing copolymerized gelatin or fibrinogen. The proteolytic activity was inhibited by specific SH proteinase inhibitors. The proteinase forms a labeled complex after its incubation with 125I-labeled cystatin. Neither FN, cathepsin D, nor any products from previous purification steps were proteolytically active under the conditions of the assay. It was suggested that the same fragment may also yield an inhibitor, since structural analogies were found between the cell-binding region of FN and SH proteinase inhibitors.

摘要

有证据表明,纤连蛋白(FN)多肽链含有一种潜在的蛋白酶。人血浆FN用组织蛋白酶D切割成三个主要片段:140 kDa和70 kDa的单链以及140 kDa的双链多肽。根据它们对肝素-琼脂糖的亲和力实现了它们的分离。一个140 kDa的单链片段(H-1)在第一个峰中被洗脱。该肽对应于已经描述的源自FN中央部分的片段;它包含一个低亲和力肝素结合位点、一个游离SH基团和一个细胞结合位点。经过还原并通过制备性聚丙烯酰胺凝胶电泳进一步纯化后,该片段显示出自发分解,这可能归因于蛋白水解降解。当在含有共聚明胶或纤维蛋白原的凝胶中通过NaDodSO4/聚丙烯酰胺凝胶电泳测试时,25至95 kDa的亚片段产生了相同的28 - 30 kDa蛋白水解活性双峰。蛋白水解活性被特异性SH蛋白酶抑制剂抑制。该蛋白酶与125I标记的胱抑素孵育后形成标记复合物。在测定条件下,FN、组织蛋白酶D或先前纯化步骤的任何产物均无蛋白水解活性。有人提出,同一片段可能还会产生一种抑制剂,因为在FN的细胞结合区域和SH蛋白酶抑制剂之间发现了结构相似性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/540d/386289/48e03b7b8386/pnas00319-0032-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验